Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Tandem Diabetes Care Stock Quote

Tandem Diabetes Care (NASDAQ: TNDM)

Price as of July 15, 2024, 4:00 p.m. ET

Tandem Diabetes Care Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
TNDM +55.69% -27.68% -6.27% -76%
S&P +24.51% +86.32% +13.24% +214%

Tandem Diabetes Care Company Info

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.

News & Analysis

The Fool has written over 100 articles on Tandem Diabetes Care.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.